Tarsus Pharmaceuticals (TARS) EBIT Margin (2021 - 2026)
Tarsus Pharmaceuticals (TARS) posted EBIT Margin of -11.45% for Q2 2026, up 10.16 percentage points from -21.61% a year earlier but down 7.67 percentage points from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EBIT Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Tarsus Pharmaceuticals was -8.00%, up 25.17 percentage points year-over-year; for FY2025, it came in at -15.72%, up 50.18 percentage points from FY2024.
- Annual EBIT Margin shows a four-year change of +5.59 percentage points (FY2021 to FY2025).
- In prior years, Tarsus Pharmaceuticals' EBIT Margin was -65.90% in FY2024 (+754.63 pp), -820.53% in FY2023 (-577.61 pp), -242.92% in FY2022 (-221.60 pp) and -21.32% in FY2021.
- Quarterly EBIT Margin has run from a low of -4274.56% in Q4 2021 to a high of -3.78% in Q1 2026 over five years.
- On a year-over-year basis, EBIT Margin has increased in each of the last eight quarters, with an average year-over-year change of +339.14 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 4123.95 percentage points; the weakest was Q1 2022, with a drop of 3653.75 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -3.78% (Q1 2026), -5.26% (Q4 2025) and -12.24% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Tarsus Pharmaceuticals | 3.40 Bn | 2.35 Bn | 161.80 Mn | -11.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.45% |
| Mar 31, 2026 | -3.78% |
| Dec 31, 2025 | -5.26% |
| Sep 30, 2025 | -12.24% |
| Jun 30, 2025 | -21.61% |
| Mar 31, 2025 | -33.55% |
| Dec 31, 2024 | -36.77% |
| Sep 30, 2024 | -52.29% |
| Jun 30, 2024 | -81.60% |
| Mar 31, 2024 | -136.47% |
| Dec 31, 2023 | -339.94% |
| Sep 30, 2023 | -2,187.87% |
| Mar 31, 2023 | -998.08% |
| Dec 31, 2022 | -150.61% |
| Jun 30, 2022 | -34.20% |
| Mar 31, 2022 | -3,621.71% |
| Dec 31, 2021 | -4,274.56% |
| Sep 30, 2021 | -1,266.53% |
| Jun 30, 2021 | 33.07% |
| Mar 31, 2021 | 32.05% |
API Access
Tarsus Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();